Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Biochem. 2011 Dec;44(17-18):1434-9. doi: 10.1016/j.clinbiochem.2011.09.016. Epub 2011 Oct 6.

Potential of fluorescent metalloproteinase substrates for cancer detection.

Author information

1
Program in Vascular Biology and Department of Surgery, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA.

Erratum in

  • Clin Biochem. 2012 May;45(7-8):601.

Abstract

OBJECTIVES:

MMP-2, MMP-9, their complexes and ADAM12 are detected in the urine of breast cancer patients and predict disease status. We assessed the use of FRET-based substrates in an assay to distinguish breast cancer patients from controls.

DESIGN AND METHODS:

Substrates with varying specificities for MMP-9 and MMP-2 and several ADAMs were screened. Flsub21 and Flsub13, substrates for ADAM12 and ADAM8 respectively, were studied.

RESULTS:

Flsub21 and Flsub13 cleavage activities were detected in the urine of patients with invasive and metastatic breast cancers at significantly higher frequencies compared to controls. Our model predicted probabilities of 90% when both Flsub21 and Flsub13 were positive, 65% when Flsub21 alone was positive, 55% when Flsub13 alone was positive and 20% when both substrates were negative.

CONCLUSIONS:

These data suggest the potential utility of FRET substrates to non-invasively identify invasive and/or metastatic breast cancer.

PMID:
22001071
PMCID:
PMC3232457
DOI:
10.1016/j.clinbiochem.2011.09.016
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center